+804.4%
AAOI vs GSK
+47.2%
+757.2%
-77.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.0% | 0.0% | +2.0% | +2.0% |
| 7D | -0.2% | -3.5% | +3.4% | -1.6% |
| 30D | -23.7% | -3.4% | -20.2% | -24.5% |
| 3M | -39.0% | -8.1% | -30.9% | -40.2% |
| 6M | -17.0% | -11.1% | -5.9% | -19.1% |
| YTD | +202.2% | +0.7% | +201.5% | +210.3% |
| 1Y | +292.4% | +20.1% | +272.3% | +331.6% |
| 3Y | +804.4% | +46.1% | +758.3% | +917.1% |
| All | +804.4% | +47.2% | +757.2% | +917.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling